STACEY AZZOLINO: Open Payments
NPI 1770796625 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 13 payments from 7 companies in 2025. Trend: 2023 $641 · 2024 $1,954 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $63 |
| Astellas Pharma US Inc | 3 | $60 |
| Edwards Lifesciences Corporation | 1 | $47 |
| Boston Scientific Corporation | 1 | $42 |
| Medtronic, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
Products named: SAPIEN 3 Ultra RESILIA, WATCHMAN FLX, Vyloy, Fabhalta, PLUVICTO, COREVALVE EVOLUT R, Xospata, CALQUENCE.
Industry payments across FL — which companies pay providers there.
